LM N°2/ 2024. The state of the art in 2024. HYALURONIC ACID, FROM THE ENDOGENOUS MOLECULE TO INJECTABLE GELS. Denis COUCHOUREL.

The state of the art in 2024 HYALURONIC ACID: FROM ENDOGENIC MOLECULE TO INJECTABLE GELS Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY ENDOGENIC HYALURONIC ACID In 1934, Karl Meyer and John Palmer described a new polysaccharide initially isolated from bovine vitreous humor. This substance contained a uronic acid and a sugar [...].
LM N°2/ 2024. The state of the art in 2024.rHEOLOGICAL CHARACTERIZATION OF STYLAGE® FILLING PRODUCTS WITH REGARD TO THEIR INJECTION PLANS AND CLINICAL PERFORMANCE. Virginie BIGAND, Ph.D, Florence BRUNEL, Ms.c, Frédéric TRANCHEPAIN, Ph.D.

STATE OF THE ART IN AH RESEARCH RHEOLOGICAL CHARACTERIZATION OF STYLAGE® DERMAL FILLERS WITH REGARD TO THEIR INJECTION SCHEDULES AND CLINICAL PERFORMANCE. Virginie BIGAND, Ph.D., Florence BRUNEL, Ms.c., Frédéric TRANCHEPAIN, Ph.D. Figure 1. IPN-like® interpenetrating network INTRODUCTION: RETICULATION OF HA. WHY? The aging process of the skin is characterized, among other things, by [...].
LM N°2/ 2024. STATE OF RESEARCH IN 2024. ALTERATIONS IN MUCOSAL TRANSUDATION IN VULVOVAGINAL ATROPHY: WHAT MECHANISMS ARE INVOLVED? THE ROLE OF HYALURONIC ACID IN INFLUENCING VAGINAL LUBRICATION. Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY

The state of the art in 2024 on HA research ALTERATIONS OF MUQUEOUS TRANSSUDATION IN VULVO- VAGINAL ATROPHIES: WHAT MECHANISMS ARE INVOLVED? THE ROLE OF HYALURONIC ACID IN INFLUENCING VAGINAL LUBRICATION. Denis COUCHOUREL, PhD Scientific and Medical Director, VIVACY Laboratories INTRODUCTION In 2014, the [...]
LM N°1/ 2024. GOOD PRACTICES FOR THE PREPARATION OF AUTOLOGOUS PLATELET-RICH PLASMA (PRP-A) FROM THE RECIPIENT'S OWN BLOOD. Daphné V. DIERMAN, PhD Pharmacist, Antoine TURZI, CEO RegenLab.

New cell therapies characterized as autologous (organic substance from which the donor and
the recipient is the same individual) are found on the market, their preparations are dependent on
the use of medical devices certified by an accredited organization, enabling them to minimize
risks of contamination (infection), standardize the steps in a closed circuit and demonstrate the efficiency of the process.
therapeutic.
We will discuss the preparation of biological products derived from human blood for therapeutic purposes.
and specifically the preparation of autologous platelet-rich plasma (PRP-A).
LM N°1/ 2024. EFFECTIVE HAIR RESTORATION IN PATIENTS WITH BALDNESS USING A BIO-REVITALIZATION TREATMENT. A PRELIMINARY PROSPECTIVE MEDICAL STUDY. Pilar REYES, MD, Gustavo H. LEIBASCHOFF, MD.

EFFECTIVE HAIR RESTORATION IN BALDNESS PATIENTS USING A COMPREHENSIVE BIO-REVITALIZATION TREATMENT. A PRELIMINARY PROSPECTIVE MEDICAL STUDY. Pilar REYES, MD, Gustavo H. LEIBASCHOFF, MD. Dr. María Del Pilar Reyes Agüero, Aesthetic Medicine & Cosmetic Surgery. C. P. Ortiz Rubio 1325, Medardo González, 88550 Reynosa, Tamps., Mexico President of the WSCG [...]
LM N°1/ 2024. PLATELET-RICH PLASMA AND SYMPTOMATIC GONARTHROSIS. SUMMARY OF INTERNATIONAL RECOMMENDATIONS. M.Delcros

PLATELET-RICH PLASMA AND SYMPTOMATIC GONARTHROSIS. SUMMARY OF INTERNATIONAL RECOMMENDATIONS. Marine DELCROS, MD. The 4 grades of gonarthrosis according to Kellgren & Lawrence INTRODUCTION Interest in autologous platelet-rich plasma (PRP) emerged in the 1970s with the discovery of growth factor release by platelets [1]. This [...]
LM N°1/ 2024. OVERVIEW OF REGENLAB'S PATENTED TECHNOLOGIES. Andreas PIGNI. Legal Affairs, RegenLab SA.

OVERVIEW OF REGENLAB'S PATENTED TECHNOLOGIES Andreas PIGNI Legal Affairs, RegenLab SA INTRODUCTION RegenLab SA has established itself as a pioneer and leader in regenerative medicine, known for its innovative technologies that synergistically use platelet-rich plasma (PRP) in combination with various bioactive/therapeutic agents, thus providing solutions to [...].
LM N°1/ 2024. ANGIOGENESIS, A KEY STEP IN TISSUE REGENERATION, IS MODULATED BY PLATELETS. Sarah BERNDT PhD, Gilles CARPENTIER, Axel TOLLANCE PhD, Antoine TURZI.

All you need to know. Another look ANGIOGENESIS, A KEY STEP IN TISSUE REGENERATION, IS MODULATED BY PLAQUES. Sarah BERNDT PhD1, Gilles CARPENTIER2, Axel TOLLANCE PhD1,3, Antoine TURZI1 1 Regen Lab SA, 1052 Le Mont-sur-Lausanne, Switzerland. 2 Gly-CRRET Research Unit 4397, Université Paris-Est Créteil, Créteil, France. 3 Department of Orthopedic Surgery, Geneva [...]
LM N°2 / 2023. Theme 3. Clinical research in regenerative medicine with REGENLAB. Evaluation of alpha-2-macroglobulin and extracellular vesicles in RegenLab platelet-rich plasma.

Clinical research in regenerative medicine with REGENLAB. Evaluation of alpha-2-macroglobulin and extracellular vesicles in RegenLab platelet-rich plasma Daniel A. GRANDE, Michael R. TUCKER, Andrew R. SAMUEL, Antoine TURZI. TUCKER, Andrew R. SAMUEL, Antoine TURZI 1. Pr Daniel A. Grande, MD. Professor, Molecular Medicine and Orthopedic Surgery, Feinstein Institutes for Medical Research at Hofstra/Northwell (USA). [...]
LM N°2 /2023. Theme 3. Clinical research on regenerative medicine with REGENLAB. Platelet Rich Plasma (PRP), an adjuvant treatment for alopecia after breast cancer. Pr Barbara Hersant (Paris)

Plasma Riche en Plaquettes (PRP): an adjuvant treatment for alopecia Pr Barbara HERSANT Plastic Surgery, Hôpital Henri-Mondor, APHP Scientific director of the AIME congress Editorial director of Look et Medecine